Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Marina Beltrami-Moreira MD, PhD

Marina Beltrami-Moreira MD, PhD

Clinical Fellow, Department of Medicine, Division of Hematology & Medical Oncology, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York

Marina Beltrami-Moreira, MD, PhD, is a clinical fellow in Hematology and Medical Oncology at NewYork-Presbyterian Hospital-Weill Cornell Medicine. She is passionate about caring for older adults with hematological conditions. She contributed significantly to our current understanding of the effects of COVID-19 vaccines in patients with immune thrombocytopenia. Her current laboratory-based research focuses on Age-Related Clonal Hematopoiesis.

Dr. Beltrami completed medical school and graduate studies in Brazil. She pursued postdoctoral research training in Vascular Biology at the Brigham and Women’s Hospital/Harvard Medical School. Dr. Beltrami completed her Internal Medicine residency at the Yale School of Medicine-affiliated Norwalk Hospital in 2019 served there as Chief Resident, supporting the Hospital's first response to the COVID-19 pandemic.


Dr. Beltrami-Moreira reports the following: 
  • Spouse - former employee within 24 months: Jounce Therapeutics, Kadmon Inc.